Cerebral palsy (CP) is a neurological disorder that affects a person’s movement and posture, caused by damage to or abnormalities within the brain or spinal cord. It is the most common motor disability affecting children, with it occurring in up to two out of every 1,000 births in the United States. The cause of cerebral palsy is often unknown, although in some cases it is believed to have either been from environmental factors such as a stroke, or from problems during the pregnancy or shortly after birth. The effects of cerebral palsy depend on the severity and amount of damage to the brain. In its mildest form, movement may be limited in only one arm or leg, or the affected person may experience some speech or coordination issues. In severe cases, an individual may be unable to walk or talk, and rely on the use of wheelchairs and other assistive technology to move around. Cerebral palsy has a range of associated issues including communication and sensory difficulties, learning delays, and difficulty with daily activities such as taking care of personal hygiene, dressing and eating. Many forms of therapy are used to help treat the physical and mental effects, such as physiotherapy, occupational therapy, speech therapy and the use of assistive technology. The aim of treatment is to improve a person’s wellbeing and quality of life. Treating the physical effects of CP means people may have better movement, coordination and balance, and have improved ability to carry out daily tasks. Treating the mental effects of CP can help reduce anxiety, depression and stress, improve emotional wellbeing, self-esteem and confidence levels, and encourage independent living skills. Overall, CP is a very complex neurological disorder and cannot be cured. However, with treatment and support, people living with CP can lead fulfilling and independent lives.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom